MHRA clears inavolisib, offering new option for returning breast cancer
The oral, film-coated tablet is licensed for patients whose cancer has returned during or shortly after hormone therapy
The oral, film-coated tablet is licensed for patients whose cancer has returned during or shortly after hormone therapy
The audit was completed with zero critical and zero major observations
Nitrosamines have prompted evolving global guidelines that demand rigorous industry oversight
GLP-1 therapies are among the fastest-growing drug classes worldwide, projected to drive a $95 billion obesity market by 2030
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
Owlet’s push comes as parents demand smarter, more dependable nursery tech
Solventum aims to accelerate innovation in acute wound care, expand its market reach, and deliver enhanced solutions for patients, clinicians, and shareholders
The company will soon be launching a new portfolio of products in this segment
Subscribe To Our Newsletter & Stay Updated